Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Maria Skibińska"'
Publikováno v:
Brain Sciences, Vol 14, Iss 6, p 583 (2024)
Background: Alcohol use disorder (AUD) is related to mental and somatic disorders that result in alcohol withdrawal syndrome (AWS), with 30% of AWS cases leading to life-threatening delirium tremens (DTs). Currently, studies do not support using any
Externí odkaz:
https://doaj.org/article/2e70a9dd5f66442cba42be4cfa0675da
Autor:
Agnieszka Permoda-Pachuta, Magda Malewska-Kasprzak, Maria Skibińska, Krzysztof Rzepski, Monika Dmitrzak-Węglarz
Publikováno v:
Brain Sciences, Vol 13, Iss 10, p 1358 (2023)
Objectives: One of the current challenges in psychiatry is the search for answers on how to effectively manage drug-resistant depression. The occurrence of drug resistance in patients is an indication for the use of electroconvulsive therapy (ECT). T
Externí odkaz:
https://doaj.org/article/6044d11d0b3840fa9b99211a70f42d13
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
A recent view on schizophrenia phenomenology underlines the impaired relations between the mind and the body. An aberrant feeling of ipseity may be the real source of suffering of the patients from psychosis and impacts general symptomatology. The di
Externí odkaz:
https://doaj.org/article/df617f9ea86749ddb19b7b2cbb6bd155
Autor:
Anna Jasińska-Mikołajczyk, Katarzyna Drews, Katarzyna Domaszewska, Grzegorz Kolasa, Marta Konofalska, Katarzyna Jowik, Maria Skibińska, Filip Rybakowski
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
BackgroundCognitive deficits occur in most patients with affective disorders. The role of neurotrophic factors (e.g., BDNF) as modulators of brain plasticity affecting neurocognitive abilities has been emphasized. Neurotrophin concentrations may chan
Externí odkaz:
https://doaj.org/article/442e9e1af0fe40b298cff3dd6c2779a1
Autor:
Przemysław Zakowicz, Maria Skibińska, Karolina Wasicka-Przewoźna, Bartosz Skulimowski, Filip Waśniewski, Aneta Chorzepa, Maciej Różański, Joanna Twarowska-Hauser, Joanna Pawlak
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
The accurate assessment of suicide risk in psychiatric, especially affective disorder diagnosed patients, remains a crucial clinical need. In this study, we applied temperament and character inventory (TCI), Barratt impulsiveness scale 11 (BIS-11), P
Externí odkaz:
https://doaj.org/article/77a751de1fe04ab3b262b5fbb2740d1f
Autor:
Ewa Ferensztajn-Rochowiak, Monika Dmitrzak-Węglarz, Aleksandra Szczepankiewicz, Maria Skibińska, Sebastian Kliwicki, Agnieszka Permoda-Pachuta, Aleksandra Suwalska, Piotr Czerski, Joanna Pawlak, Joanna Hauser
Publikováno v:
Psychiatria Polska. 56:1003-1016
Lit jest lekiem normotymicznym, stosowanym z wyboru w leczeniu profilaktycznym choroby afektywnej dwubiegunowej (ChAD). Skuteczność profilaktyczna litu może być uwarukowana czynnikami genetycznymi, związanymi częściowo z predyspozycją do chor
Publikováno v:
Current Problems of Psychiatry. 22:318-331
Introduction: This study attempts to assess the concentration of intracellular matrix metalloproteinase (MMP-9) before and after the treatment of depressive episodes with ECT therapy and also to correlate the concentration of this enzyme with the use
Schizophrenia onset in the developmental age has strong neurodevelopmental burden and links with a poorer prognosis. The approach to diagnosis is still based on symptomatic description without objective validation. In the study we aimed to compare th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7be09f98c7a08d6523f051179eddfca3
https://doi.org/10.21203/rs.3.rs-2097374/v1
https://doi.org/10.21203/rs.3.rs-2097374/v1
Autor:
Marcin Górniak, Maria Skibińska, Filip Rybakowski, Jan Jaracz, Monika Dmitrzak-Węglarz, Janusz Rybakowski
Publikováno v:
Pharmacotherapy in Psychiatry and Neurology. 37:205-219
Autor:
Przemysław Zakowicz, Joanna Pawlak, Paweł Kapelski, Monika Wiłkość-Dębczyńska, Agnieszka Szałkowska, Joanna Twarowska-Hauser, Janusz Rybakowski, Maria Skibińska
Publikováno v:
Behavioural brain research. 419
Cognitive deficits are the core factors impacting quality of life among patients diagnosed with schizophrenia. Effective method of treatment for this domain of symptoms remains lacking. Recent evidence suggests the link between impaired cognition and